Namizato Dai, Iwasaki Masae, Ishikawa Masashi, Nagaoka Ryuta, Genda Yuki, Kishikawa Hiroaki, Sugitani Iwao, Sakamoto Atsuhiro
Department of Anesthesiology and Pain Medicine, Graduate School of Medicine, Nippon Medical School.
Department of Endocrine Surgery, Graduate School of Medicine, Nippon Medical School.
J Nippon Med Sch. 2019 Dec 3;86(5):263-268. doi: 10.1272/jnms.JNMS.2019_86-408. Epub 2019 May 17.
Intraoperative neuromonitoring (IONM) might reduce the incidence of injury to the recurrent laryngeal nerve (RLN) during thyroidectomy. Although dislocation of endotracheal tube surface electrodes can lead to false-positive IONM results (loss of signal), the risk factors for dislocation and the effects of muscle relaxants are unclear. Therefore, to identify factors that affect IONM results, we examined the frequency and risk factors for tube dislocation after cervical extension before surgery, the effect of sugammadex administration, and the correlation between IONM results and postoperative RLN palsy.
Thirty-nine patients scheduled for thyroidectomy from October 2016 to April 2017 were enrolled. All patients underwent standard IONM and pre- and postoperative laryngoscopy. Differences in patient characteristics in the tube dislocation group and non-dislocation group, and differences in amplitude during vagal stimulation before and after sugammadex administration, were assessed by the Mann-Whitney test or Fisher's exact test.
Tube dislocation occurred in 27 patients (69%). Sterno-cricoid distance was significantly shorter in the dislocation group (n=27) than in the non-dislocation group (n=12) (43.88 [32.2-55.91] mm vs 49.46 [40.66-55.91] mm, respectively; p=0.048). Without sugammadex, amplitude during vagal stimulation was sufficient for monitoring. Nine patients had new-onset RLN palsy, which was transient in all patients. The sensitivity of IONM was 100%, the positive predictive value was 60%, and the negative predictive value was 100%.
The present findings suggest that anesthesiologists should use video laryngoscopy to correct tube dislocation and that a rocuronium dose of 0.6 mg/kg, without sugammadex, is adequate for IONM.
术中神经监测(IONM)可能会降低甲状腺切除术中喉返神经(RLN)损伤的发生率。尽管气管导管表面电极移位会导致IONM出现假阳性结果(信号丢失),但其移位的危险因素以及肌肉松弛剂的影响尚不清楚。因此,为了确定影响IONM结果的因素,我们研究了术前颈部伸展后导管移位的频率和危险因素、舒更葡糖钠给药的影响以及IONM结果与术后RLN麻痹之间的相关性。
纳入2016年10月至2017年4月计划行甲状腺切除术的39例患者。所有患者均接受标准IONM及术前和术后喉镜检查。采用Mann-Whitney检验或Fisher精确检验评估导管移位组和未移位组患者特征的差异,以及舒更葡糖钠给药前后迷走神经刺激时振幅的差异。
27例患者(69%)发生导管移位。移位组(n = 27)的胸骨 - 环状软骨距离显著短于未移位组(n = 12)(分别为43.88 [32.2 - 55.91] mm和49.46 [40.66 - 55.91] mm;p = 0.048)。在未使用舒更葡糖钠的情况下,迷走神经刺激时的振幅足以进行监测。9例患者出现新发RLN麻痹,所有患者均为短暂性。IONM的敏感性为100%,阳性预测值为60%,阴性预测值为100%。
目前的研究结果表明,麻醉医生应使用视频喉镜纠正导管移位,并且在不使用舒更葡糖钠的情况下,0.6 mg/kg的罗库溴铵剂量足以进行IONM。